TABLE OF CONTENTS
1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 31
1.3 OVERVIEW OF LATIN AMERICA ADVANCED WOUND CARE MARKET 35
1.4 CURRENCY AND PRICING 37
1.5 LIMITATIONS 37
1.6 MARKETS COVERED 37
2 MARKET SEGMENTATION 40
2.1 MARKETS COVERED 40
2.2 LATIN AMERICA ADVANCED WOUND CARE MARKET: GEOGRAPHICAL SCOPE 41
2.3 YEARS CONSIDERED FOR THE STUDY 41
2.4 DBMR TRIPOD DATA VALIDATION MODEL 42
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 45
2.6 DBMR MARKET POSITION GRID 46
2.7 MULTIVARIATE MODELING 47
2.8 PRODUCTS TYPE LIFELINE CURVE 47
2.9 VENDOR SHARE ANALYSIS 48
2.10 SECONDARY SOURCES 49
2.11 ASSUMPTIONS 49
3 EXECUTIVE SUMMARY 50
4 PREMIUM INSIGHTS 52
5 MARKET OVERVIEW 53
5.1 DRIVERS 55
5.1.1 INCREASING CASES OF CHRONIC WOUNDS 55
5.1.2 NEW PRODUCT LAUNCHES 56
5.1.3 INCREASING NUMBER OF PATIENTS UNDERGOING SURGICAL PROCEDURES 56
5.1.4 GROWING GERIATRIC POPULATION 57
5.1.5 RISING AWARENESS PROGRAMS 58
5.1.6 INCREASING RESEARCH AND DEVELOPMENT 58
5.2 RESTRAINTS 59
5.2.1 HIGH COST ASSOCIATED WITH THE TREATMENT 59
5.2.2 STRINGENT MANUFACTURING POLICIES 60
5.2.3 PRODUCT RECALL 60
?
5.3 OPPORTUNITIES 61
5.3.1 TECHNOLOGICAL ADVANCEMENT IN WOUND CARE 61
5.3.2 GROWTH POTENTIAL IN EMERGING ECONOMIES 62
5.3.3 STRATEGIC INITIATIVES BY THE COMPANIES 63
5.4 CHALLENGES 64
5.4.1 LACK OF SKILLED LABOR FORCE 64
5.4.2 SIDE EFFECTS AND ADVERSE EFFECTS ASSOCIATED WITH CHRONIC WOUNDS 65
6 LATIN AMERICA ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE 66
6.1 OVERVIEW 67
6.2 DRESSING 70
6.2.1 FOAM DRESSING 70
6.2.2 FILM DRESSING 71
6.2.2.1 TRANSPARENT 71
6.2.2.2 NON TRANSPARENT 71
6.2.3 ALGINATE DRESSING 71
6.2.4 HYDROCOLLOID DRESSING 71
6.2.5 ANTIMICROBIAL 71
6.2.6 HYDROGEL DRESSING 71
6.2.7 COLLAGEN DRESSING 71
6.2.8 POLYACRYLATE DRESSINGS 71
6.2.9 SUPER ABSORBENT DRESSING 72
6.2.9.1 NON-ADHERENT 72
6.2.9.2 ADHERENT 72
6.2.10 WOUND CONTACT LAYER 72
6.2.11 WOUND CLEANSERS 72
6.2.12 HONEY DRESSINGS 72
6.2.13 OTHERS 72
6.3 THERAPY DEVICES 73
6.3.1 NEGATIVE PRESSURE WOUND THERAPY (NPWT) 73
6.3.1.1 DISPOSABLE NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES 73
6.3.1.2 PORTABLE NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES 74
6.3.1.3 STANDALONE NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES 74
6.3.2 PHYSICAL THERAPIES 74
6.3.2.1 LASER THERAPY 74
6.3.2.2 EXTERNAL SHOCK WAVE THERAPIES 74
6.3.2.3 ELECTRICAL STIMULATION 74
6.3.2.4 OTHERS 74
6.3.3 PRESSURE RELIEF DEVICES 75
6.3.3.1 MATTRESS 75
6.3.3.2 BED 75
6.3.4 HYPERBARIC OXYGEN CHAMBERS 75
6.3.4.1 MONOPLACE 75
6.3.4.2 MULTIPLACE 75
6.3.4.3 TOPICAL 76
6.3.5 WOUND DEBRIDEMENT DEVICES 76
6.3.5.1 ULTRASOUND 76
6.3.5.2 HYDROSURGICAL 76
6.3.5.3 MECHANICAL 76
6.3.5.4 OTHERS 76
6.3.6 OTHERS 76
6.4 BIOLOGICS 77
6.4.1 ALLOGRAFTS 77
6.4.1.1 CULTURED ALLOGRAFTS 77
6.4.1.2 HUMAN DERMAL LAYER 77
6.4.2 XENOGRAFTS 77
6.4.3 SYNTHETIC SKIN GRAFTS 78
6.4.4 GROWTH FACTORS 78
6.4.4.1 PLATELET DERIVED GROWTH FACTORS (PDGF) 78
6.4.4.2 EPIDERMAL GROWTH FACTORS (EGF) 78
6.4.4.3 GRANULOCYTE COLONY STIMULATING FACTORS (G-CSF) 78
6.4.4.4 BASIC FIBROBLAST GROWTH FACTORS (BFGF) 78
6.4.4.5 KERATINOCYTE GROWTH FACTORS (KGF) 79
6.4.4.6 PLATELET RICH PLASMA (PRP) 79
6.4.4.7 TALACTOFERRIN ALFA 79
6.4.4.8 THROMBIN PEPTIDE (TP508) 79
6.4.4.9 OTHERS 79
6.5 OTHERS 79
7 LATIN AMERICA ADVANCED WOUND CARE MARKET, BY WOUND TYPE 80
7.1 OVERVIEW 81
7.2 PRIMARY WOUND CARE 84
7.2.1 SURGICAL WOUNDS 84
7.2.1.1 CLASS III 84
7.2.1.2 CLASS IV 84
7.2.1.3 CLASS II 84
7.2.1.4 CLASS I 85
7.2.2 ULCERS 85
7.2.2.1 DIABETIC FOOT ULCERS 85
7.2.2.2 VENOUS ULCERS 85
7.2.2.3 PRESSURE ULCERS 85
7.2.2.4 OTHERS 85
7.2.3 PAPER CUTS 85
7.2.4 SMALL CUTANEOUS WOUNDS 85
7.2.5 OTHERS 86
7.3 SECONDARY WOUND CARE 86
7.3.1 TRAUMATIC WOUNDS 86
7.3.2 BURNS 86
7.3.2.1 THERMAL BURNS 86
7.3.2.2 ELECTRICAL BURNS 87
7.3.2.3 CHEMICAL BURNS 87
7.3.2.4 RADIATION BURNS 87
7.3.2.5 FRICTION BURNS 87
7.3.3 OTHERS 87
8 LATIN AMERICA ADVANCED WOUND CARE MARKET, BY END USER 88
8.1 OVERVIEW 89
8.2 HOSPITALS 91
8.3 WOUND CARE CENTERS 91
8.4 AMBULATORY CENTERS 92
8.5 HOME HEALTHCARE 92
8.6 CLINICS 92
8.7 OTHERS 92
9 LATIN AMERICA ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL 93
9.1 OVERVIEW 94
9.2 DIRECT TENDERS 97
9.3 RETAIL 97
10 LATIN AMERICA ADVANCED WOUND CARE MARKET, BY COUNTRY 98
10.1 OVERVIEW 98
10.2 BRAZIL 109
10.3 MEXICO 116
10.4 ARGENTINA 123
10.5 COLOMBIA 130
10.6 PERÚ 137
10.7 CHILE 144
10.8 ECUADOR 151
10.9 BOLIVIA 158
10.10 REPÚBLICA DOMINICANA 165
10.11 PARAGUAY 172
10.12 NICARAGUA 179
10.13 EL SALVADOR 186
10.14 COSTA RICA 193
10.15 PANAMA 200
10.16 URUGUAY 207
10.17 VENEZUELA 214
10.18 REST OF LATIN AMERICA 221
11 LATIN AMERICA ADVANCED WOUND CARE MARKET, COMPANY LANDSCAPE 222
12 SWOT & DBMR ANALYSIS 223
12.1 SWOT ANALYSIS 223
12.1.1 STRENGTH: - STRONG GLOBAL PRESENCE 223
12.1.2 WEAKNESS: - LOW REVENUE GENERATION IN MARKET FOCUSED SEGMENT 223
12.1.3 OPPORTUNITY: - EXPANDING BUSINESS THOROUGH THEIR SUBSIDIARIES 224
12.1.4 THREAT: - FLUCTUATIONS IN CURRENCY CONVERSION 225
12.2 DATA BRIDGE MARKET RESEARCH ANALYSIS 225
13 COMPANY PROFILE 226
13.1 MoLNLYCKE HEALTH CARE AB 226
13.1.1 COMPANY SNAPSHOT 226
13.1.2 PRODUCT PORTFOLIO 226
13.1.3 RECENT DEVELOPMENT 227
13.2 SMITH & NEPHEW 228
13.2.1 COMPANY SNAPSHOT 228
13.2.2 REVENUE ANALYSIS 229
13.2.3 PRODUCT PORTFOLIO 229
13.2.4 RECENT DEVELOPMENT 230
13.3 BSN MEDICAL. (A SUBSIDIARY OF ESSITY AKTIEBOLAG) 231
13.3.1 COMPANY SNAPSHOT 231
13.3.2 REVENUE ANALYSIS 231
13.3.3 PRODUCT PORTFOLIO 232
13.3.4 RECENT DEVELOPMENTS 233
13.4 PAUL HARTMANN CHILE SPA 234
13.4.1 COMPANY SNAPSHOT 234
13.4.2 PRODUCT PORTFOLIO 234
13.4.3 RECENT DEVELOPMENT 235
13.5 CARDINAL HEALTH 236
13.5.1 COMPANY SNAPSHOT 236
13.5.2 REVENUE ANALYSIS 237
13.5.3 PRODUCT PORTFOLIO 237
13.5.4 RECENT DEVELOPMENT 238
?
13.6 3M 239
13.6.1 COMPANY SNAPSHOT 239
13.6.2 REVENUE ANALYSIS 240
13.6.3 PRODUCT PORTFOLIO 240
13.6.4 RECENT DEVELOPMENTS 241
13.7 ACELL INC. 242
13.7.1 COMPANY SNAPSHOT 242
13.7.2 PRODUCT PORTFOLIO 242
13.7.3 RECENT DEVELOPMENTS 242
13.8 B. BRAUN MELSUNGEN AG 243
13.8.1 COMPANY SNAPSHOT 243
13.8.2 REVENUE ANALYSIS 244
13.8.3 PRODUCT PORTFOLIO 244
13.8.4 RECENT DEVELOPMENT 245
13.9 COLOPLAST GROUP 246
13.9.1 COMPANY SNAPSHOT 246
13.9.2 REVENUE ANALYSIS 247
13.9.3 PRODUCT PORTFOLIO 247
13.9.4 RECENT DEVELOPMENT 247
13.10 CONVATEC GROUP PLC 248
13.10.1 COMPANY SNAPSHOT 248
13.10.2 REVENUE ANALYSIS 249
13.10.3 PRODUCT PORTFOLIO 249
13.10.4 RECENT DEVELOPMENT 250
13.11 JOHNSON & JOHNSON SERVICES, INC. 251
13.11.1 COMPANY SNAPSHOT 251
13.11.2 REVENUE ANALYSIS 252
13.11.3 PRODUCT PORTFOLIO 252
13.11.4 RECENT DEVELOPMENT 252
14 QUESTIONNAIRE 253
15 CONCLUSION 257
16 RELATED REPORTS 258